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Background: The family of D-isomer specific 2-hydroxyacid dehydrogenases (2HADHs) contains a wide range of
oxidoreductases with various metabolic roles as well as biotechnological applications. Despite a vast amount of
biochemical and structural data for various representatives of the family, the long and complex evolution and
broad sequence diversity hinder functional annotations for uncharacterized members.
Results: We report an in-depth phylogenetic analysis, followed by mapping of available biochemical and structural
data on the reconstructed phylogenetic tree. The analysis suggests that some subfamilies comprising enzymes with
similar yet broad substrate specificity profiles diverged early in the evolution of 2HADHs. Based on the phylogenetic
tree, we present a revised classification of the family that comprises 22 subfamilies, including 13 new subfamilies
not studied biochemically. We summarize characteristics of the nine biochemically studied subfamilies by
aggregating all available sequence, biochemical, and structural data, providing comprehensive descriptions of the
active site, cofactor-binding residues, and potential roles of specific structural regions in substrate recognition. In
addition, we concisely present our analysis as an online 2HADH enzymes knowledgebase.
Conclusions: The knowledgebase enables navigation over the 2HADHs classification, search through collected
data, and functional predictions of uncharacterized 2HADHs. Future characterization of the new subfamilies may
result in discoveries of enzymes with novel metabolic roles and with properties beneficial for biotechnological
applications.
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2HADHs can act either as reductases or dehydroge-
nases, use NADP(H) or NAD(H) as a cofactor, and pos-
sess varied substrate specificities. Due to their diversity
of accepted substrates, the enzymes are implicated in
different cellular processes, e.g., antibiotic resistance [1],
photorespiration [2], or anaerobic glycolysis [3]. In
humans, glyoxylate reductase (GRHPR) plays a critical
role in the removal of the metabolic by-product glyoxy-
late from the liver [4]. Mutations in the GRHPR gene
were found to cause primary hyperoxaluria type II, a rare
disease characterized by endogenous overproduction of
oxalate [4].le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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paralogs. For example, the ɑ-proteobacterium Sinorhizo-
bium meliloti has 16 paralogs, Arabidopsis thaliana has
nine, Escherichia coli has five, and the human genome
has four. Unfortunately, the exact biological function of
the majority of these proteins is unknown because func-
tional annotations of 2HADHs in protein databases rely
on activities obtained for a small subset of selected sub-
strates or on annotations available for the closest charac-
terized homologs. Despite previous efforts [5–7], there is
no consistent and comprehensive classification of
2HADHs into subfamilies. Moreover, no systematic
studies show to what extent properties of studied mem-
bers can be inter- or extrapolated, hindering assignment
of biological processes and substrates. Thus, it is often
difficult to predict the type of processes that uncharac-
terized 2HADH members are associated with. Better
predictions and annotations would be particularly help-
ful for studies of medically relevant organisms, which
often have several 2HADH enzymes with unclear func-
tions. In addition, they will help to discover desired en-
zymes of potential biotechnological applications among
a large number of environmental sequences collected
from metagenomic samples.
Beyond their multiple cellular functions, 2HADHs have
already been shown to possess a range of biotechnology
applications. Enantiomerically pure 2-hydroxy acids are
versatile building blocks for the synthesis of a variety of
significant chiral compounds, which can be used as anti-
microbial compounds [8], antitumour antibiotics [9], bio-
degradable polymers [9] or angiotensin-converting
inhibitors [10]. As some 2HADHs can reduce a broad
spectrum of 2-keto acids with high efficiency, they are
used in systems for highly stereoselective production of
selected chiral α-hydroxy carboxylic acids [11, 12]. Fur-
thermore, formate dehydrogenase is used for efficient
NADH regeneration in bioreduction systems [13], stimu-
lation of certain metabolic pathways on a cellular level
[14], and reduction of the atmospheric CO2 level [15].
Nevertheless, despite of the amount of biochemical, struc-
tural, and genomic data, finding or engineering stable and
efficient enzymes for particular biotechnological processes
have been difficult. Comprehensive classification of the
family will help identification of highly efficient and
thermodynamically stable enzymes for selected biotechno-
logical processes, and better understanding of functional
roles of different structural regions will guide rational de-
sign of such biocatalysts.
To better guide functional predictions, rational design,
and new applications of these highly important enzymes,
we analyzed biochemical and structural information
available for 2HADH members in the light of their evo-
lution. We systematically describe the active site,
cofactor-binding residues, and potential roles of specificstructural regions in substrate recognition for all the
nine biochemically studied subfamilies. Furthermore, we
provide a web-based knowledgebase to facilitate func-
tional annotation of uncharacterized members and guide
finding of enzymes with particular biochemical
characteristics.
Results
A high-quality phylogenetic tree of the 2HADH family
We calculated multiple phylogenetic trees in various ways
(using neighbor-joining and maximum-likelihood ap-
proaches) and used nodes with high split support values
(i.e., greater than 0.5) to assign sequences to subfamilies.
Here, we define “subfamily” as a group of proteins that ap-
pear consistently as a clade in all the phylogenetic trees,
which presumably share a similar function. Although low
support values for the bifurcations close to the mid-point
root indicate uncertainty of the path of the early evolution
of the 2HADH family, the major subfamilies appear con-
sistently as separate clades in the computed trees (Fig. 1).
The 22 identified subfamilies include nine in which at
least one member has been studied biochemically. Five of
these subfamilies appeared in the previous classification
[5]: 3-phosphoglycerate dehydrogenases (SERA), formate
dehydrogenases (FDH), C-terminal binding proteins
(CTBP), 4-phosphoerythronate dehydrogenase (PDXB),
and D-lactate dehydrogenases (LDHD).
Due to little sequence similarity among distant 2HADH
members (as noted earlier [16, 17]), noteworthy differ-
ences in subfamily classification may arise from the use of
alternative methodologies for phylogenetic reconstruction.
Notably, three subfamilies were classified into a single
glyoxylate/hydroxypyruvate reductase (GHPR) cluster in
the earlier neighbor-joining phylogenetic trees based on
ClustalW sequence alignments [5, 6]. Here, these subfam-
ilies are referred to as: glyoxylate/hydroxypyruvate reduc-
tases A (GHRA; including GhrA from E. coli, GHRA_
ECOLI), glyoxylate/hydroxypyruvate reductases B (GHRB;
including GhrB from E. coli, GHRB_ECOLI, and PtxD
from Pseudomonas stutzeri, PTXD_PSEST) and
broad-substrate-specificity dehydrogenases (DDH; includ-
ing DDH from Haloferax mediterranei, DDH_HALMT).
In all reconstructed trees, DDH and GHRA appear as
closely related, yet separated, clades. Similarly, the poly-
phyletic origin of the GHRB subfamily and the clade
encompassing GHRA and DDH subfamilies is supported
in all reconstructed trees. Although in previous studies
some GHRA and GHRB members showed similar sub-
strate profiles and were classified as one group [5], in our
analyses, they consistently appear as distantly related
clades, separated early in the evolution of the 2HADH
family (Fig. 1). Within GHRB, we also found a significant
premise for a horizontal gene transfer from bacteria to
plants, potentially occurred after early diversification of
Fig. 1 A maximum-likelihood tree of the 2HADHs from 111 representative organisms. The tree was computed with FastTree 2.1.7 [106] based on a high-
quality, structure-based multiple sequence alignment and visualized with Archaeopteryx [108]. The separated subfamilies were defined based on high
support values of the corresponding bifurcations and consistency between trees computed using different approaches. Proteins studied biochemically are
marked with circles, which denote their substrates (large, most efficient in terms of kcat/KM; small, additional). SERA, 3-phosphoglycerate dehydrogenases;
FDH, formate dehydrogenases; CTBP, C-terminal binding proteins; PDXB, 4-phosphoerythronate dehydrogenase; LDHD, D-lactate dehydrogenases; GHRA,
glyoxylate/hydroxypyruvate reductases A; GHRB, glyoxylate/hydroxypyruvate reductases B; GHRC, glyoxylate/hydroxypyruvate reductases C; DDH, broad-
substrate-specificity dehydrogenases; and X1-X13, subfamilies not studied biochemically. Nodes with local support values greater than 0.8 are denoted by
grey squares. The tree in Newick format with branch support values can be found in Additional file 3: Data file S1
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plementary Results).
Besides GHRA, GHRB, and DDH, a fourth clade in-
cludes an enzyme previously shown to act as a hydroxy-
pyruvate/glyoxylate reductase. HprA from the facultative
methylotroph Methylobacterium extorquens (DHGY_ME-
TEA) plays a central role in carbon assimilation, as it con-
verts hydroxypyruvate to glycerate in a critical step of the
serine cycle [19]. The corresponding subfamily, which we
name glyoxylate/hydroxypyruvate reductases C (GHRC),
comprises bacteria from various phyla as well as a meth-
anogenic archaeon, Methanococcus maripaludis, and has
not been featured in previous classifications.
Along with the nine studied subfamilies, 13 additional
clades not studied biochemically (X1-X13), includingeight with representatives with a determined 3D struc-
ture (Additional file 2: Figure S1), could be defined with
high support values (Additional file 3: Data file S1). Sin-
gle long branches were left outside the classification;
however, if more sequences were added, they could con-
stitute additional clades.
Substrate specificity of the 2HADH enzymes
To systematically describe the properties of the 2HADH
subfamilies, we collected enzymatic parameters for the
characterized representatives from the available litera-
ture (Additional file 4: Table S1). The collected data in-
clude 77 enzyme-substrate pairs with determined
catalytic efficiency, defined as kcat/KM, based on which
14 compounds are ‘best’ substrates for at least one
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a just a few substrates, most of them can be considered
as promiscuous enzymes based on the collected data.
The only exception constitutes FDHs, for which no sub-
strates other than formate were determined so far; FDHs
work through a different reaction mechanism, without
typical stages of acid-base catalysis [20, 21]. Cumula-
tively, the 2HADH proteins are versatile catalysts
in vitro—in total, they were shown to accept 33 com-
pounds with either cofactor (Additional file 4: Table S1).
The median kcat/KM for the ‘best’ substrates is 1.45 × 10
5
M− 1 s− 1 (Additional file 5: Figure S2), thus 2HADHs
can be considered as moderately efficient catalysts, as
compared to global trends for enzymes [22]. Interest-
ingly, the two subfamilies most conserved regarding se-
quence and function, FDH and CTBP, comprise the least
efficient catalysts, characterized by kcat/KM of 10
2–103
M− 1 s− 1 and ~ 103M− 1 s− 1, respectively (Additional file
5: Figure S2). On the other hand, some of the most di-
vergent subfamilies, GHRB and LDHD, encompass the
most promiscuous and efficient enzymes.
In the studied in vitro conditions, most of the 2HADH
subfamilies comprise members acting as reductases to-
wards 2-keto acids, with a simultaneous oxidation of
NADH or NADPH. Only three subfamilies contain rep-
resentatives natively working as dehydrogenases, i.e., to-
wards formate (FDH), 3-phosphoglycerate (SERA) and
4-phospho-D-erythronate (PDXB). In addition, two de-
hydrogenases were described in the highly heteroge-
neous GHRB cluster, i.e., phosphonate dehydrogenase
from P. stutzeri [23] and D-mandelate dehydrogenase
from Rhodotorula graminis [24]; also, the only character-
ized member of the GHRC subfamily was shown to pos-
sess glycerate dehydrogenase activity [19]. Unlike
reductases, which have preferences for either NADH or
NADPH, almost all wild-type dehydrogenases efficiently
employ only NAD+ as a cofactor, which is expected
given the typical redox state of a cell [20]. However,
some formate dehydrogenases have been shown to pos-
sess dual cofactor specificity (i.e., working with NAD+
and NADP+) [19, 25].
In general, the data suggest that well-evolved
enzyme-substrate interactions are rather rare among
2HADHs. Median affinity to the “best” (i.e., catalyzed
with the highest efficiency) substrates, approximated as
KM (or K1/2 in case of non-Michaelis-Menten behavior),
is lower than the average affinity for metabolic enzymes
in general (KM of 600 μM against 130 μM [22, 26], re-
spectively). Only a few 2HADHs display higher affinity
(compared to the global average) for their native sub-
strates. Most of these are promiscuous 2HADH en-
zymes, with E. coli PdxB in the extremum (KM of
2.9 μM, Additional file 5: Figure S2) [27]. As described
for other enzyme families [26], a substrate considered asthe physiological or most efficient in vitro in one sub-
family is often secondary in other subfamilies (Fig. 1). In
2HADHs, glyoxylate, hydroxypyruvate, and pyruvate re-
currently appear as accepted substrates in most
subfamilies.
Analysis of crystal structures
Besides kinetics, a wealth of structural data is also avail-
able for 2HADH enzymes. Out of the 22 defined sub-
families, 16 contain representative proteins with solved
crystal structures (Additional file 2: Figure S1). Among
the 121 2HADH structures available in the PDB, 40 were
solved with both a cofactor and a ligand bound in the
active site (Additional file 6: Table S2). Nevertheless, al-
most half of the structures have not been discussed in
the literature (as indicated by the lack of a linked refer-
ence publication in the PDB). Several subfamilies (DDH,
GHRC, X4, X6, X7, X9, X10, X12, and X13) have repre-
sentative structures available in the PDB, but not a single
one was presented in the scientific literature.
2HADHs usually act as homodimers, where each
monomer is composed of two domains: a
cofactor-binding domain with a classical NAD(P)-bind-
ing Rossmann fold, and a substrate-binding (or catalytic)
domain with a modified (flavodoxin-like) Rossmann fold
[28] (Fig. 2). The cofactor-binding domain is embedded
in the substrate-binding domain and characterized by a
more conserved sequence. The active site is located in
the cleft formed between the two domains and is built
mainly with residues from the cofactor-binding domain.
According to solved crystal structures of apo and holo
forms, 2HADHs can exist in either “open” and “closed”
conformational states. Transition from the open to the
closed conformation is essential for the formation of the
enzyme active site and for catalysis [29]. Generally, crys-
tal structures of 2HADHs without the cofactor bound
display the open conformation, and holo forms display
the closed conformation. However, there are a few ex-
ceptions to that general trend, which are likely caused by
compounds present in the crystallization cocktails (e.g.,
sulfates) and different crystal environments [30]. The
general consensus is that the 2HADH enzymes are in a
dynamic equilibrium between the open and closed states
and that the binding of cofactor shifts the equilibrium
towards the closed state [29]. Because the substrate
binds to residues from both domains, its binding is likely
to contribute to shifting the equilibrium towards the
closed state.
The structure-based alignment of representative se-
quences shows conservation of several residues (Add-
itional file 7: Figure S3), suggesting a crucial role for
these amino acids across the whole family. Some of them
are well known to perform crucial functions, yet others
were not previously discussed in the literature (e.g.,
AB
Fig. 2 Crystal structure of a 2HADH from Sinorhizobium meliloti (PDB ID: 5v7n) complexed with a cofactor (NADP+) and a reaction product (2-keto-D-
gluconic acid). Cofactor-binding and substrate-binding domains are indicated by brackets. a, Secondary structure elements are labeled; the other subunit
of the dimer is translucent. b, Highly conserved residues (> 90% in all 2HADH sequences) are labeled
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The importance of some of these residues could only be
determined by family-wide sequence comparison, as op-
posed to analyses of single structures, which only high-
light important features of a particular enzyme. Wedivide the functions of highly conserved residues (> 90%
conservation across all 2HADH sequences) into three
categories—residues binding the cofactor, contributing
to catalysis, and maintaining overall structure (Fig. 2). In
the following analysis, the sequence numbering is
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subfamily, Q92LZ4_RHIME (PDB ID: 5v7n).
Residues binding the cofactor
Among the residues crucial for cofactor-binding, a
highly conserved pyrophosphate-binding GXXGXGXXG
motif (residues 146–154 in Q92LZ4_RHIME) is com-
mon for Rossmann-fold dinucleotide-binding proteins.
The motif is located in the region connecting the first
strand of the β-sheet to the α-helix of the Rossmann fold
(i.e., βA-αC). It contributes to the structural arrange-
ment of the pyrophosphate bridge of the cofactor by as-
suring nearly optimal dihedral angles [31]. Although
mutations of the glycine residues result in a drastic loss
of enzymatic activity [32], neither of them are totally
conserved among all 2HADH sequences (Fig. 3). It was
shown that an Ala-to-Gly mutation improves protein
thermal stability and decreases KM towards NADH [33].
Two other conserved residues, aspartate (Asp254) and
valine (Val255) contribute to binding of the pyridine ring
of the cofactor [34, 35].
The specificity towards the cofactor [NAD(H) vs.
NADP(H)] is effectively defined by the residues located
in the βB-αD loop at the pocket that binds adenine and
ribose moieties of the cofactor (Fig. 3). Five of the nine
biochemically characterized subfamilies (CTBP, FDH,
LDHD, PDXB, and SERA) have a highly conserved as-
partate residue in this region, corresponding with a pref-
erence for NADH [36]. Many of GHRA enzymes haveFig. 3 Sequence logos of selected regions critical for substrate and cofacto
structure-based alignment was obtained for selected structures with PROM
from 111 representative organisms. The sequence logos were generated w
least 90% members possess an amino acid (i.e., with at most 10% gapped
implicated in substrate specificity. Catalytic triad residues are denoted by re
Additional file 7: Figure S3the characteristic motif [ST]R[ST]X[RK] in the same
βB-αD loop – a conserved sequence fingerprint
corresponding with specificity towards NADP(H). Other
three biochemically characterized subfamilies do not
have highly conserved residues in the region, suggesting
varying cofactor specificity within these subfamilies.
Residues of the active site
The catalytic mechanism for the NAD+-dependent oxi-
dation of 2-hydroxy acids (and the reverse reduction) is
dependent on an internal acid-base catalyst, typically
histidine [37, 38]. During the oxidation reaction, a hy-
dride ion leaves the C2 atom of a substrate and attacks
the C4 atom of the NAD+ pyridine moiety, and a proton
moves from the hydroxy group of the substrate to the
histidine of the active site [29]. Together with the histi-
dine, two more residues within the active site—Arg and
Glu/Asn—are thought to contribute directly to the reac-
tion and are referred to as the “catalytic triad” [39]. The
highly conserved arginine stabilizes and polarizes the
bound substrate, whereas the glutamate (or asparagine
in formate dehydrogenases) stabilizes the protonated
form of the catalytic histidine.
The mode of the substrate binding was subject to long
discussions over several years; at least three modes of
2-keto/2-hydroxy acid binding were proposed [29, 34].
As our analysis of crystal structures shows, despite 40
structures being solved with both a cofactor and a ligand
bound in the active site, only eight of them represent ar binding in the nine biochemically studied 2HADH subfamilies. The
ALS3D and used as a seed alignment for other 2HADH sequences
ith WebLogo, showing columns for which in at least one subfamily at
positions). Rectangles with colored backgrounds comprise loops
d triangles. Sequence logos of the full-length alignments are shown in
Matelska et al. BMC Evolutionary Biology          (2018) 18:199 Page 7 of 23true ternary complex—a complex with a reduced cofac-
tor and a reduced substrate, or with an oxidized cofactor
and an oxidized substrate (Additional file 6: Table S2).
The remaining triple complex structures have an inhibi-
tor, a substrate analog, or a solute bound in the active
site and do not provide a complete model of substrate
binding (except for FDH, whose substrate is not a
2-hydroxy acid), as discussed earlier [29]. In 2006, the
first crystal structure of a true ternary complex of a
2HADH (human GHRB, GRHPR_HUMAN, PDB ID:
2gcg) was published [38], demonstrating the interactions
between the substrate and catalytic residues within the
active site and confirming one of the earlier proposals
for the mode of substrate binding (Fig.4). Later, the same
mode of substrate binding was observed in all other
2HADH true ternary complexes with clearly observed
electron densities for the ligands: human CTBPs
(CTBP1_HUMAN and CTBP2_HUMAN) in complex
with NAD+ and 4-methylthio-2-oxobutyric acid (PDB
ID: 4lce and 4lcj) [40], GHRB from Rhizobium meliloti
(Q92LZ4_RHIME) in complex with NADP+ and
2-keto-D-gluconic acid (PDB ID: 5v7n), and an enzyme
from Aquifex aeolicus that belongs to the X9 subfamily
(O66939_AQUAE) in complex with a cofactor and un-
known ligand, interpreted as a complex with NADH and
lactate (PDB ID: 3 kb6) [41] (Fig. 4). As seen in Fig. 4,
one of the ligands (4-methylthio-2-oxobutyric acid
bound to CtBP1 in complex with NAD+; PDB ID: 4lce)
is modeled in a slightly unusual orientation, with the
carboxyl group rotated around the C1-C2 bond. This lig-
and corresponds to the unusual C2′-endo conformation
of the ribose moiety of the cofactor seen in the same fig-
ure. However, both the ligand and the cofactor show in-
complete occupancy and poor electron density in theA
Fig. 4 Active site of canonical 2HADHs: (a), active site residues, reaction su
[NADP(H) or NAD (H))]; (b), structural support of the active site arginine. Sh
with 2-keto-D-gluconic acid and NADP+ (PDB ID: 5v7n, shown in wider stic
ID: 2gcg), human CTBP1 with 4-methylthio-2-oxobutyric acid and NAD+ (PD
NAD+ (PDB ID: 4lcj), and A. aeolicus subfamily X9 member with lactic acid a
blue and red, respectively, with carbon atoms in green (for PDB ID: 5v7n) o
and product are shown with gray dashed lines. Residues are labeled accord
residues (i.e., present in > 90% of 2HADH sequences) are shown in bold ancrystal structure and should be interpreted with caution.
To address this issue, we downloaded the structural
model and structure factors of 4lce that were deposited
in the PDB and re-refined this structure using recently
published guidelines [42]. Re-refinement revealed that
the sugar moiety is likely in the C3′-endo conformation
(as in all other 2HADH structures) and that the orienta-
tion of the keto-acid is largely consistent with other
structures.
These structures show the mode of 2-keto/2-hydroxy
acid binding by 2HADH that involves four highly con-
served residues (Gly73, Arg230, Glu259, and His277,
conserved in more than 90% of all 2HADH sequences)
and a variable residue that bind the substrate via a
main-chain amide (Val72). Two consecutive main chain
amines from the β4-α4 loop (Fig. 3, Fig. 4) form hydro-
gen bonds to the carboxylate atoms of the substrate, po-
sitioning the carboxyl group and thus orienting the
substrate relative to the cofactor. The first amide comes
from Val72, which is often replaced with another small
residue such as alanine, serine, or threonine (Additional
file 7: Figure S3). The second amide comes from a highly
conserved glycine (Gly73). The only exception from this
general pattern is subfamily X13, which has asparagine
and leucine residues in these consecutive positions, re-
spectively. Arg230 is the most conserved residue in the
active site because only arginine provides the positively
charged guanidinium group that can bind the substrate
via two atoms and thus properly orient the substrate in
addition to stabilizing its charge. The guanidinium group
binds both the reducible/oxidizable keto/hydroxyl oxy-
gen, presumably leading to its polarization, and the
single oxygen of the substrate carboxylate, thus contrib-
uting to the orientation of the substrate [38]. His277 isB
bstrates/products (2-keto acids/2-hydroxy acids), and cofactors
own are selected residues of five ternary complexes: S. meliloti GHRB
ks), human GRHPR with 2,3-dihydroxypropanoic acid and NADP+ (PDB
B ID: 4lce), human CTBP2 and 4-methylthio-2-oxobutyric acid and
nd NAD+ (PDB ID: 3 kb6). Oxygen and nitrogen atoms are shown in
r gray (in other structures). Hydrogen bonds between protein residues
ing to the sequence of PDB ID: 5v7n. Labels of highly conserved
d underlined
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system between the histidine and the carboxylic acid
residue Glu259. Notably, the four residues responsible
for direct binding of the core of the substrate belong to
both the catalytic (Val72 and Gly73) and the
cofactor-binding domains (Arg230 and His277), thus
making the interdomain cleft closure a necessary pre-
requisite for catalysis. The roles of the active site resi-
dues in the catalysis are supported by multiple
mutagenesis studies [21, 43–46].
The residues Arg230, Glu259, and His277, often re-
ferred to as the “catalytic triad” [39] are conserved in al-
most all 2HADHs (Fig. 3). However, there are single cases
of substitutions in these positions. In most FDHs, glutam-
ate is substituted with glutamine, which broadens the op-
timal pH range for substrate binding [46]. Histidine,
which is thought to exchange a proton in the redox reac-
tion, is substituted by lysine in SERA type IIIK, and by
tryptophan in X4 (PDB ID: 4njo and 1qp8, respectively;
Additional file 8: Figure S4). Despite the histidine substitu-
tion for lysine and the absence of glutamate, a SERA type
IIIK enzyme was shown to be catalytically active, presum-
ably because lysine is also capable of maintaining two pro-
tonated states of the side chain [47]. However, the indole
nitrogen in tryptophan is never protonated under physio-
logical conditions (pKa = − 2.4) and it cannot lose the pro-
ton; thus, it cannot serve as a catalytic residue that would
provide a proton for the catalysis. The molecular function
of the members of X4 with tryptophan instead of histidine
should still be studied experimentally (see section: New
uncharacterized subfamilies).
Residues maintaining the structure
Among the three conserved residues with structural
function, asparagine (Asn227) and glycine (Gly231), lo-
cated in the βE-αG loop, are responsible for positioning
and conformational stabilization of the catalytic arginine
Arg230 (Fig. 4). Gly231, which follows Arg230, gives the
conformational flexibility to the protein main chain that
is necessary to position the arginine side chain in the
proper orientation. Asn227, separated by two residues
from the arginine, locks the arginine main chain by
forming hydrogen bonds to its main chain oxygen and
to the main chain nitrogen of Gly229. Asn227 is highly
conserved in 2HADHs, because asparagine side chain
has the capacity of forming the two hydrogen bonds
with the main chain atoms (one atom accepts hydrogen,
and the other is donor, Fig. 4). This highly specific con-
formation of the polypeptide chain requires extra con-
formational flexibility of the main chain around the
residue preceding Arg230, which is provided by glycine
(Gly229). Interestingly, Gly229 is not highly conserved
in 2HADHs and is often replaced by a residue with a
small side chain (Ala, Ser). However, these residues arealways found to be Ramachandran plot outliers in all
known crystal structures (PDB IDs: 5tx7, 5dt9, 3oet,
2o4c, and others).
The third residue, located downstream of the cross-
over helix αE of the cofactor-binding domain, usually as-
partate (93% of the sequences; Asp195), is substituted to
arginine in 3% of the sequences. This residue forms
hydrogen bonds to residues in adjacent loops, probably
contributing to the maintenance of the fold.
Residues contributing to substrate specificity
Based on the collected data, an enzyme with narrow sub-
strate specificity in the 2HADH family is exceptional, and
different subfamilies, separated early in evolution, often ex-
hibit similar substrate profiles (Fig. 1, Additional file 4:
Table S1). Therefore, determination of positions crucial for
substrate specificity (which we term “specificity determin-
ing positions”) that are general for the entire family is a par-
ticularly difficult or, maybe even impossible, task. Previous
analyses of solved crystal structures and sequence align-
ments suggested that specific residues govern substrate dis-
crimination within single subfamilies [29, 35, 38, 39]. In
addition, some attempts were made to change substrate
specificity of single enzymes by introducing point muta-
tions in the proximity of the active site [48]. However, the
mutagenesis data is scarce and hypotheses about molecular
features governing substrate specificity among 2HADHs
are largely based on crystal structures of ternary complexes
solved with inactive substrate analogs or products.
Substrate specificity stems largely from the acquisition
of unique loop regions and the adaptation of the
physico-chemical nature of the substrate-binding pocket.
Our analysis of available crystal structures shows that
residues that can contact a variable substituent at the C2
carbon atom are found—depending on the structure and
substrate—in up to eight regions of the sequence (Fig. 3,
Additional file 8: Figure S4). Four of them are supplied
by the substrate-binding domain (loops β1-α1, β3-α3,
β4-α4, and helix α5). Two regions are located within
loops connecting the two domains (loops β5-αA and
βG-α5). Selectivity in 2HADH also appears to be
dependent on the interactions within oligomeric assem-
blies: in many complexes, some residues in the substrate
pocket, usually aromatic or acidic, are supplied by an-
other subunit of a dimer (i.e., αB′-βA′). Furthermore, in
PDXB, a dimerization domain specific to PDXB can sup-
plement the pocket with a substrate-binding arginine
residue (PDB ID: 2o4c, “PDXB_dim” in Additional file 7:
Figure S3).
Due to local structural changes of the enzymes, the
broad range of physicochemical properties of their sub-
strates, and the location of the catalytic pocket at the
interface of two domains, 2HADH subfamilies developed
various modes of substrate discrimination (Additional
Matelska et al. BMC Evolutionary Biology          (2018) 18:199 Page 9 of 23file 8: Figure S4). Below, we provide the first attempt to
systematically characterize the contributions of specific
regions of 2HADH structures to the substrate specificity
of subfamilies, based on available crystal structures.
However, as noted before for other enzyme families, sub-
strate specificity may go beyond the physicochemical
and steric characteristics of the active site, i.e., it may de-
pend on global protein dynamics, the transition from
the ‘close’ to ‘open’ conformation, and the mechanism of
substrate entrance/exit [49, 50].
Descriptions of the subfamilies
The properties of the nine biochemically studied sub-
families (Fig. 1) are summarized in Table 1. Figure 3
shows the sequence logos of their regions critical for
substrate and cofactor binding. Figure 5 shows their
abundance in the genomes of model organisms.
CTBP
C-terminal binding proteins (CtBPs) can be found in ver-
tebrates (e.g., rats and humans) and arthropods (e.g., Dros-
ophila melanogaster [51]), yet members studied
enzymatically include only two human paralogs. The ani-
mal CtBPs localize to both the nucleus and the cytoplasm,
and much effort has been made to study transrepression
pathways in which they may be involved [52].
CtBPs were first identified as transcriptional corepres-
sors targeting many transcriptional regulators [53] and
playing critical roles during development of both inverte-
brates and vertebrates [52]. Although the precise mechan-
ism of the corepressor activity is still under investigation,
it is known that CtBPs recognize the consensus PXDLS
motif in DNA-binding and other transcription-related
proteins [54, 55]. Later studies confirmed that they also
possess dehydrogenase activity, and the NAD+-dependent
conformational change is thought to be essential to their
corepression activity [56, 57]. Human CtBP1
(CTBP1_HUMAN) reduces a number of substrates, in-
cluding glyoxylate and pyruvate, with relatively low activ-
ity, using NADH as a cofactor [58] (βB-αD loop, Fig. 3).
Human CtBP1 shows the highest catalytic efficiency with
4-methylthio-2-oxobutyric acid (MTOB), an intermediate
of the methionine salvage pathway [58]. The saturation
curve shows biphasic behavior, with marked substrate in-
hibition at elevated concentrations [58]. Nevertheless, the
most relevant physiological substrates for CtBPs and their
role in the corepressor function remain unclear.
The homolog from A. thaliana (CTBP_ARATH,
C-terminal binding protein AN) differs substantially
from the animal CtBPs in sequence, lacks the catalytic
residues, and does not seem to regulate transcription
[59]. For this reason, the plant homologs were not in-
cluded in the CTBP subfamily and considered as its sis-
ter clade.Based on the available crystal structures solved in
complex with a cofactor and MTOB, it was observed
that the sulfur atom of MTOB forms a sulfur–π inter-
action with tryptophan from the βG-α5 loop (Trp318 in
PDB ID: 4lce, Additional file 8: Figure S4). This inter-
action is thought to confer specificity towards MTOB
[40]. Other bulky residues, such as a conserved histidine
and tyrosine from the βG-α5 loop, form the tight bind-
ing pocket and appear to constrain the size of substrates
accepted.
In the case of CtBP1, the tetramer assembly is pre-
ceded by a dimeric intermediate, in which the trypto-
phan (Trp318) from the βG-α5 loop functions as a
switch for effective dimerization following NAD+ bind-
ing (Additional file 8: Figure S4, PDB ID: 4lce) [60, 61].
Mutation of this residue to phenylalanine reduced
dimerization and completely abolished tetramerization,
what suggested that NAD(H)-dependent dimerization
occurs with Trp318 required to effectively induce the
strand switch, bringing the dimer pairs into a spatial
context permissive for homotetramerization [61].
DDH
This subfamily is named after the only biochemically stud-
ied representative, D-2-hydroxyacid dehydrogenase (Ddh)
from Haloferax mediterranei (DDH_HALMT), and com-
prises proteins spread over the taxonomic tree, including
eukaryotes (e.g., fungi and protists), archaea and bacteria
(cyanobacteria and actinobacteria). Ddh from H. mediter-
ranei catalyzes the reduction of a broad range of
2-ketocarboxylic acids, with a preference for those having
an unbranched chain of 4–5 carbon atoms, such as
2-ketoisoleucine [62]. It exhibits dual cofactor specificity,
yet shows better catalytic efficiency with NADPH [62].
The sequence conservation within the βB-αD loop does
not display the respective aspartate residue defining the
specificity towards NAD(H) (Fig. 3), suggesting that most
enzymes within the DDH subfamily would display prefer-
ence towards NADPH. Although some archaeal genomes
(e.g., the halophilic mesophile Haloferax volcanii, Fig. 5)
encode as many as four DDH representatives, their func-
tion is not known.
Recently, three crystal structures of DDH_HALMT were
solved in complex with combinations of NAD+, NADP+,
NADPH, 2-ketohexanoic acid, and 2-hydroxyhexanoic acid
(PDB IDs: 5mha, 5mh5, 5mh6). Although the DDH sub-
family displays high sequence variability, some common
features can be distinguished based on the sequence align-
ment with other 2HADH subfamilies (Fig. 3). For example,
the β1-α1 loop harbors a considerably long insertion, which
folds into a tightly packed 3/10-helix in the crystal struc-
tures. Furthermore, a highly conserved tryptophan within
the αB-A loop from the other subunit (Trp122 in
DDH_HALMT), which is thought to preclude larger
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Fig. 5 Abundance of the nine biochemically studied 2HADH subfamilies in selected model organisms. The size of each square corresponds to
the number of proteins belonging to a given subfamily encoded in the given organism. The tree topology was obtained from iTOL [112], and
proteomes were downloaded from KEGG [113] (Additional file 9: Data file S2)
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and SERA subfamilies, is located far away from the active
site (Additional file 8: Figure S4). In addition, small residues
within the β5-αA loop would allow accommodation of
large and hydrophobic substrates, whereas large residues fa-
cing the active site from the 3/10-helix (such as Arg14 in
DDH_HALMT) could possibly prevent the binding of
branched substituents (Additional file 8: Figure S4).
FDH
Formate dehydrogenases (FDHs) represent a highly con-
served subfamily of enzymes, characterized by a scat-
tered taxonomic distribution. They are present in
various bacteria (i.e., Firmicutes and proteobacteria) and
eukaryotes (plants, yeasts, and fungi), and catalyze the
NAD+-dependent oxidation of formate to carbon diox-
ide. The aspartate residue that defines the specificity for
NAD+ is conserved within the subfamily (βB-αD loop,
Fig. 3). The formate oxidation is the simplest reaction
catalyzed by 2HADHs, as it lacks the proton release
step. It is specified by a direct transfer of hydride ion
from the substrate onto the C4 atom of the nicotinamide
moiety of NAD+. Since formate is not a 2-hydroxy acid,
the mode of substrate binding in FDH differs from other
2HADHs [21]. FDHs constitute the most studied
2HADH subfamily, and their characteristics have been
reviewed extensively [33, 63].FDHs play a pivotal role in methanol utilization in
methylotrophic microorganisms (yeast and bacteria),
supplying them with energy and reducing equivalents
[21]. As opposed to microbiological FDHs, which func-
tion in cytoplasm, plant FDHs localize to the mitochon-
dria and are key players in the cell stress response
caused by both exogenic and endogenic factors [33].
The vast majority of FDHs studied so far accept only
formate as a substrate and NAD+ as a cofactor, though
some were found to possess double cofactor specificity
[25, 64]. A number of enzymes have also been shown to
oxidize esters and thioesters of formic acids [63]; how-
ever, the physiological significance of the additional sub-
strates has not been confirmed.
Interestingly, although FDHs are considered highly spe-
cific enzymes, they possess relatively low affinity to for-
mate, characterized by a KM of 3–10mM [21]. Affinities
to the cofactor are usually 1–2 orders of magnitude
higher, with most KM values ranging from 10 to 100 μM
[27, 65, 66]. Similarly, catalytic efficiencies are relatively
small, yet higher in bacterial FDHs than methylotrophic
yeast FDHs. Improvement of the catalytic parameters of
FDHs by genetic engineering is an important issue, as
FDH enzymes are widely used for NADH regeneration in
enzymatic syntheses of optically active compounds [21].
A wealth of structural data [21, 30, 35] and computa-
tional studies [67, 68] is available for the FDH subfamily,
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As reflected by the high sequence similarity among its
members (Fig. 1), their active site environment is almost
invariable. A common feature of all FDHs is an extended
β3-α3 loop harboring the PF[HW] P sequence motif,
which appears to significantly reduce the size of the ac-
tive site. The invariant prolines maintain the aromatic
residues in stereochemically constrained positions, fur-
ther supported by stacking of their aromatic rings (Add-
itional file 8: Figure S4). In consequence, the active site
remains rigid and tightly packed, perfectly tailored for
accommodation of small substrates.
GHRA
In previous classifications [5, 6], this subfamily (repre-
sented by Rhizobium etli GxrA and E. coli GhrA) was
classified jointly with GHRB. However, in our evolution-
ary trees, it consistently appeared as polyphyletic with
GHRB and clustered closely with DDH. Also, even in
the phylogenetic trees underlying the previous classifica-
tion, GHRA emerged and separated early from GHRB
[5, 6]. This subfamily comprises mostly bacterial en-
zymes (except for one protein from Nematostella vecten-
sis, closely related to β-proteobacterial enzymes), of
which three (from E. coli, R. etli, and S. meliloti) have
been characterized biochemically [5, 69]. Unlike most
GHRB members, which have hydroxypyruvate as a pre-
ferred substrate, they have been shown to work most ef-
ficiently towards glyoxylate. Their secondary substrates
include hydroxypyruvate, phenylpyruvate and pyruvate,
but not 2-keto-D-gluconate, which is a substrate for sev-
eral GHRB members. In our recent study [70], we high-
light differences between the GHRA and GHRB clades
by structural and enzymatic characterization of two
members from S. meliloti 1021.
Enzymes that belong to the GHRA clade exhibit high
sequence similarity. They share a conserved sequence
fingerprint for specificity towards NADPH at the pocket
shown to bind adenine and ribose moieties of the cofac-
tor ([ST]R[ST]X[RK] in the βB-αD loop, Fig. 3) [71].
In vitro, E. coli and S. meliloti representatives were in-
deed shown to be selective for NADPH over NADH.
However, R. etli GxrA was reported to work only with
NADH [5], which seems dubious, because the sequence
of R. etli GxrA has the fingerprint of specificity for
NADPH. The physiological function of the enzymes re-
mains to be discovered. The E. coli GhrA was proposed
to contribute to glyoxylate reduction in the cell, yet in a
dispensable manner [69].
Crystal structures of the GHRA homologs bound with
substrate analogs revealed a large hydrophobic active site
with a conserved tryptophan from the β3-α3 loop
(Trp53 in R. etli, S. meliloti or Xanthobacter autotrophi-
cus GhrA, PDB IDs: 5tsd, 4z0p or 5vg6, respectively)interacting with C2 atom substituents. The tryptophan is
unique to the GHRA subfamily and probably contributes
to selection for smaller hydrophobic or aromatic sub-
strates [70].
GHRB
This subfamily is characterized by the broadest substrate
selectivity and highest diversity in function among
2HADHs. Members of the GHRB clade bind a large var-
iety of putative physiological substrates, as diverse as
glyoxylate, hydroxypyruvate, phosphonate, D-mandalate,
2-keto-D-gluconate, phenylpyruvate, and 3,4-dihydroxy-
phenylpyruvate (Table 1). At the same time, they exhibit
a high level of promiscuity, i.e., they accept various sec-
ondary substrates, which occasionally appear as the most
efficient substrates for the most similar homologs. In
terms of kcat/KM values, they are less active than LDHDs,
with maximal values of over 105M− 1 s− 1, and although
they have similar substrate profiles, GHRBs usually do
not accept pyruvate. Enzymes falling into this subfamily
typically possess better affinity for NADPH than for
NADH (e.g., GRHPR_HUMAN, HPPR_PLESU, and
GHRB_ECOLI), but individual proteins are shown to
work more efficiently with NADH (e.g., HPR1_ARATH).
This heterogeneous subfamily spans enzymes from all
kingdoms of life (Fig. 5). Among its representatives are
yeast mandalate dehydrogenase [24], human and ar-
chaeal glyoxylate/hydroxypyruvate reductases [4, 72],
bacterial phosphonate dehydrogenases [23], plant and
fungal hydroxyphenylpyruvate reductases [6, 73], and
bacterial enzymes reducing broad ranges of substrates
[5, 69].
As hydroxypyruvate and glyoxylate constitute import-
ant compounds in various metabolic pathways, GHRB
members play crucial roles in many biological processes.
Mammalian glyoxylate reductase has a potentially pro-
tective role by metabolizing glyoxylate to the less react-
ive glycolate [4]. Hydroxyphenylpyruvate reductase from
Coleus blumei (HPPR_PLESU) is involved in rosmarinic
acid biosynthesis [73], while hydroxypyruvate reductases
from A. thaliana (HPR1_ARATH, HPR2_ARATH, and
HPR3_ARATH) are involved in photorespiratory metab-
olism [74]. In methylotrophic organisms, hydroxypyru-
vate reductase (DHGY_HYPME) plays a central role in
carbon assimilation, converting hydroxypyruvate to gly-
cerate as an essential step in the serine cycle [75].
2-keto-D-gluconate dehydrogenase from Gluconobacter
oxydans (2KGR_GLUOX) is responsible for the
utilization of the compound as a carbon source [76].
The recent age of the duplications and evidence of a
horizontal gene transfer in the recent history of the
GHRB subfamily suggest that the function and enzym-
atic behavior of its members could be extrapolated to a
limited extent. Surprisingly, some genomes encode as
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ɑ-proteobacterium Sinorhizobium sp. NGR234, a major-
ity of the GHRB homologs are expressed at relatively
low levels (i.e., less than 100 reads per kilobase per mil-
lion mapped reads, RPKM) [77]. As shown for PprA
from Wickerhamia fluorescens TK1, their transcription
could adapt to some specific metabolic conditions [6].
The enzymatic diversity of GHRB is reflected by the
active site environments in the known crystal structures.
Presence of the Gly-Ser motif within the βG-α5 loop is
correlated with the highest activity with hydroxypyruvate
(e.g., Pyrococcus horikoshii GYAR_PYRHO, H. sapiens
GRHPR_HUMAN, Plectranthus scutellarioides
HPPR_PLESU, and S. meliloti Q92LZ4_RHIME). The
serine side chain (e.g, Ser296 in PDB ID: 2gcg and
Ser280 in PDB ID: 5v7n, Additional file 8: Figure S4) is
thought to be responsible for discrimination for hydro-
xypyruvate due to the formation of a hydrogen bond
with its hydroxyl group [70]. Another highly conserved
motif – Arg-X-X-Met – is located within the ɑ5 loop in
most GHRB members. Probably the large side chains of
the Arg and Met residues prevent the binding of sub-
strates containing larger C2 substituents that extend the
C1-C2 plane (e.g., PDB ID: 5v7n, Additional file 8: Fig-
ure S4). In Rhodotorula graminis Q7LLW9_RHOGR, the
motif corresponds to Phe-His-Glu-Phe and correlates
with high activity of the enzyme towards D-mandalate.
Another important residue contributes from the other
subunit of the dimer (Trp141 in PDB ID: 2gcg, Trp134
in PDB ID: 4e5k, Additional file 8: Figure S4). This large
aromatic residue potentially precludes the binding of lar-
ger substrates: its absence in S. meliloti Q92LZ4_RHIME
coincides with activity for larger substrates, such as
2-keto-D-gluconate [70]. Variable residues within the
β3-α3 loop may be also involved in distinguishing physi-
cochemical properties of the substrate. Large hydropho-
bic side chains, such as Leu59 in GRHPR_HUMAN or
Leu70 in HPR1_ARATH, might prevent binding of sub-
strates with large substituents, whereas small hydrophilic
residues, such as Ser50 in Q92LZ4_RHIME, might pro-
mote selection towards large hydrophilic substrates.
PTXD
In a majority of the reconstructed phylogenetic trees,
the GHRB subfamily contains a small clade, PTXD, con-
taining (among others) phosphonate dehydrogenase
from Pseudomonas stutzeri (PTXD_PSEST). The enzyme
catalyzes the oxidation of phosphite to phosphate
coupled to the stoichiometric reduction of NAD+ to
NADH; besides, it was shown to reduce hydroxypyruvate
at a low level [23]. None of other tested compounds
were reduced by the enzyme; however, it has not been
tested against glyoxylate and phenylpyruvate, which are
common substrates for GHRB members.Several structures of P. stutzeri PtxD variants with im-
proved thermostability and catalytic efficiency have been
solved (Additional file 8: Figure S4, PDB ID: 4e5k) [78,
79]. It was suggested that highly hydrophobic residues
that interact with the substrate analog (Met53, Leu75,
and Leu100 in PTXD_PSEST) contribute to closing off
the active site [79]. The tight substrate-binding pocket is
shielded by Trp314 provided by the other subunit of the
dimer. However, mutagenesis studies indicate that the
tryptophan is not important for catalysis [80]. Another
residue from the active site, Arg301 located within helix
ɑ5, is thought to contribute to electrostatic interactions
with negatively charged substrates [80]. It is fully con-
served in PTXD homologs, but not in other 2HADH en-
zymes. Interestingly, the R301K mutant displayed a
slightly higher kcat than the parent PTXD, and a more
modest increase in KM for phosphite [80]. Although
three other residues—Trp314 (mentioned above),
Tyr139, and Ser295—are specific for PTXD orthologs,
site-directed mutagenesis proved them not important for
the catalysis [80].
GHRC
In addition to GHRA, GHRB, and DDH, another clade
of bacterial and archaeal proteins, here termed GHRC,
emerged to include a glyoxylate/hydroxypyruvate reduc-
tase. The only biochemically characterized member of
the subfamily—an enzyme from a methylotroph Methy-
lobacterium extorquens (DHGY_METEA)—was shown
to reduce hydroxypyruvate and glyoxylate, and to
catalyze the reverse reaction with glycerate [19]. It was
proposed to play a central role in the assimilation of car-
bon in methylotrophs, as it converts hydroxypyruvate to
glycerate (a key step in the serine cycle) [19]. The en-
zyme was shown to utilize both NADH and NADPH as
a cofactor. However, it is not known to what extent the
characteristics of this enzyme apply to other members of
this subfamily. The region responsible for cofactor speci-
ficity (i.e., the βB-αD loop) does not contain the charac-
teristic aspartate residue that defines the preference for
NADH, suggesting that NADPH may be the preferred
cofactor (Fig. 3).
A crystal structure of a GHRC representative from
Desulfovibrio vulgaris has been solved (PDB ID: 5tx7).
Although the structure is in apo form, arrangement of
the domains suggests that it adopts a closed conform-
ation. The tight substrate pocket is lined with two tryp-
tophan residues (Trp135 and Trp288), absolutely
conserved in the GHRC subfamily, and a lysine residue
(Lys52, Additional file 8: Figure S4). The lysine is located
within the “Asn-Lys” motif at the β3-α3 loop and is
present in almost all GHRC sequences. The large polar
environment created by large aromatic residues is rarely
seen in other subfamilies (Additional file 8: Figure S4),
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strates not tested in the previous biochemical assay.
LDHD
Enzymes from this subfamily can be found in bacteria
and some lower eukaryotes, such as protists, fungi and
green algae. Bacterial proteins initially annotated as
D-lactate dehydrogenases (LDHD, or D-LDH) act at the
last step of glycolysis in anaerobic conditions, by catalyz-
ing the reduction of pyruvate to D-lactate, allowing re-
generation of NAD+ from NADH [81]. These enzymes
may also play a role in other processes, as demonstrated
for VanH, which is responsible for vancomycin resist-
ance in Enterococcus faecium [82]. The only eukaryotic
D-LDH studied so far, the Chlamydomonas reinhardtii
enzyme, was shown to reduce pyruvate in fermentation
pathways in chloroplasts [83]. According to the pro-
posed role of NAD+ regeneration, this subfamily has the
highly conserved characteristic aspartate residue that de-
fines the preference towards NADH in the the βB-αD
loop (Fig. 3).
According to our phylogenetic analysis, there are two
subgroups within this subfamily: a Bacilli-specific clade
(e.g., LDHD_LACPL) and another one comprising other
bacteria (e.g., LDHD_ECOLI) and eukaryotes (B0LUZ5_
CHLRE, Fig. 1). LDHD members usually exhibit the highest
catalytic efficiency towards pyruvate (with kcat/KM over 10
6
M− 1 s− 1) and were also shown to accept other small com-
pounds, such as glyoxylate and 2-ketobutyrate, with consid-
erably lower efficiency. One exception is D-2-
hydroxyisocaproate dehydrogenase (R-HicDH) from Lacto-
bacillus casei (Q03CR3_LACC3, DHD2_LACPA), which
clusters closely with typical Bacilli D-lactate dehydroge-
nases. In a systematic screening, R-HicDH was shown to
reduce a broad range of substrates, including straight and
branched aliphatic 2-keto acids, with phenylpyruvate and
2-ketoisocaproate with the highest kcat/KM and KM, respect-
ively [84]. The kcat/KM value was three orders of magnitude
lower for pyruvate. R-HicDH slowly catalyzes reactions with
medium-size carboxylates, which, unusually, do not follow
conventional Michaelis-Menten kinetics, possibly due to
weak substrate binding [84]. In addition, E. coli LDHD was
shown to be inhibited in situ by the substrate in high con-
centrations [85].
Analyses of crystal structures describe the architec-
tures used by LDHDs to control the size and electro-
static character of the substrate-binding site [39].
Attention was especially brought to residues from loops
β3-α3, β5-αA and βG-α5 [39]. The residues at β3-α3
play a steric role in substrate selectivity: hydrophobic
and aromatic phenylalanine (e.g., Phe51 in PDB ID:
3wx0, LDHD_ECOLI) is thought to prevent binding of
substrates larger than pyruvate, whereas smaller leucine
(e.g., Leu51 in PDB ID: 1dxy, DHD2_LACPA) andglycine (Gly54 in VANH_ENTFC) contribute towards
the broader substrate specificity of LDHDs [28, 29]. The
amino acids at the β5-αA and βG-α5 loops appear to be
conserved within the LDHD subfamily: tyrosine and
phenylalanine/tyrosine, respectively, presumably restrict
the space for C2 substituents [28]. Interestingly, Arg9
from the β1-α1 loop in R-HicDH from Lactobacillus
paracasei (PDB ID: 1dxy) was proposed to be respon-
sible for the non-Michaelis-Menten kinetics observed
for this enzyme. Because of its proximity to the active
site, Arg9 may compete with the arginine of the catalytic
triad for the substrate and lead to non-productive sub-
strate binding (Additional file 8: Figure S4) [28]. How-
ever, this hypothesis awaits confirmation by site-directed
mutagenesis studies.PDXB
This small subfamily includes a group of bacterial enzymes
found in ɣ-proteobacteria and Bacteroidetes, including bio-
chemically studied PdxB from E. coli (PDXB_ECOLI). PdxB
oxidizes 4-phospho-D-erythronate to 2-keto-3-hydroxy-4-
phosphobutanoate and uses various 2-keto acids as cosub-
strates, utilizing NAD+ as a cofactor [27, 66]. The reaction is
the second step in the biosynthesis of pyridoxal phosphate
— the active form of vitamin B6 [66]. The PDXB subfamily
has a highly conserved characteristic aspartate residue that
defines the preference towards NADH in the βB-αD loop
(Fig. 3). Uniquely for 2HADHs, PDXB family proteins have
two consecutive proline residues within the loop, which are
spatially conserved in all the crystal structures of PDXB pro-
teins. Another unique feature of PDXB is presence of a
C-terminal dimerization domain (Additional file 7: Figure S3).
PDXB contains three members (from Pseudomonas
aeruginosa, Salmonella typhimurium, and Vibrio cho-
lerae) with crystal structures of the holoenzymes (PDB
IDs: 2o4c, 3oet, and 5dt9 respectively). The P. aerugi-
nosa PdxB structure has been solved with a substrate
analog (tartaric acid) bound in the active site. Based on
the structure, it was proposed that two conserved argi-
nines and a tyrosine residue anchor the phosphate moi-
ety of the native substrate via charge compensation and
hydrogen bonds [34]. Arg44 is located within the
Arg-Ser motif at the β3-α3 loop, whereas Arg346 is lo-
cated in the dimerization domain unique to PDXB (PDB
ID: 2o4c, Additional file 8: Figure S4). Thus, the
dimerization domain likely also plays a major role in
substrate recognition. The absolutely conserved residue
Tyr258 is located within the βG-α5 loop at the junction
between the cofactor-binding and substrate-binding do-
mains and presumably contributes to precise positioning
of the phosphate group within the active site. Notably,
the proposed mode of binding vastly differs from the
consensus model presented on Fig. 4.
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3-phospho-D-glycerate dehydrogenases (PGDH, or
SERA) constitute the most widespread subfamily within
2HADHs, present in almost all living organisms. They
are involved in the first step of the phosphorylated path-
way of L-serine biosynthesis from 3-phosphoglycerate,
an intermediate of glycolysis [86]. They reversibly
oxidize D-3-phosphoglycerate to hydroxypyruvic acid
phosphate utilizing NAD+ as a cofactor [86], with the re-
spective aspartate residue defining the specificity for
NAD(H) is highly conserved within the subfamily
(βB-αD loop, Fig. 3). According to the published bio-
chemical studies, SERA members rarely catalyze other
reactions.
SerA homologs were previously divided into four dis-
tinct groups — referred to as types I, II, IIIK, and IIIH
[86, 87]. Although the division was based mainly on the
presence of additional regulatory domains, it is also
reflected by the topology of the phylogenetic tree, com-
puted based on the alignment of the cofactor-binding
and substrate-binding domains (Fig. 1).
Type I enzymes are represented by the human, M. tu-
berculosis, and A. thaliana proteins. They act as tetramers
and share a conserved domain architecture, where
substrate-binding and cofactor-binding domains are
followed by two regulatory domains—an allosteric
substrate-binding (“ASB”) domain and a regulatory motif
recurring in many enzymes, termed aspartate kinase-
chorismate mutase-TyrA (“ACT”) domain. The ACT re-
gion binds amino acids (in this case, L-serine) and func-
tions in feedback inhibition of amino acid synthesis
pathways [88]. As shown for M. tuberculosis PGDH, the
second layer of regulation is provided by the ASB domain.
It appears to modulate sensitivity to L-serine by phosphate
and polyphosphate, which triggers a conversion between
oligomers with different serine-sensitive states [89].
Type II PGDHs, comprising E. coli and yeast enzymes,
contain only an additional ACT domain and also act as
tetramers. As with type I enzymes, E. coli SerA is
strongly inhibited by L-serine, which binds to the ACT
domain and allosterically regulates the velocity of the
catalyzed reaction [90]. It shows an exceptionally high
affinity to NADH, estimated as 50 nM [91]. Unlike M.
tuberculosis and rat SerA, the E. coli enzyme can also
utilize α-ketoglutarate as a substrate, yet with consider-
ably lower affinity than 3-phosphoglycerate [87, 92].
Types IIIK and IIIH indicate type III dehydrogenases,
which do not contain additional regulatory domains,
with either lysine or histidine in the active site, respect-
ively. Type III enzymes function as dimers, as opposed
to type I and II, which are active as tetramers [86]. Type
IIIK proteins are present in Bacteroidetes and protists,
including Entamoeba histolytica [93]. According to crys-
tal structures (PDB ID: 4njo) and mutagenesis studies[47], the active site is formed by arginine and lysine resi-
dues (instead of the typical Arg/His/Glu triad). Lysine is
thought to be an acid-base catalyst in the reaction, tak-
ing over the role of the catalytic histidine-glutamine pair.
The type IIIH enzymes are present in bacteria and ar-
chaea, including proteins with a determined 3D struc-
ture from P. horikoshii (PDB ID: 1wwk) and Sulfolobus
tokodaii (PDB ID: 2ekl).
In the reconstructed ML tree, 3-sulfolactate dehydro-
genase SlcC from Chromohalobacter salexigens (SLCC_
CHRSD) is grouped within the SERA clade. However,
this tree topology is not consistent among trees com-
puted using alternative methodologies; plausibly, SLCC_
CHRSD could also be placed as a sister clade to SERA
(Additional file 3: Data file S1). 3-sulfolactate is structur-
ally similar to 3-phosphoglycerate, yet SlcC is involved
in another pathway using 3-sulfolactate as a carbon
source and does not accept 3-phosphoglycerate as a sub-
strate [94].
Despite the relative sequence variability in the SERA
subfamily, the available crystal structures show similar
solutions for recognition of the negatively charged sub-
strate, which is based on the presence of at least two
conserved positively charged residues positioning the
phosphate moiety (Additional file 8: Figure S4). In par-
ticular, the Arg-Ser motif located within the β3-α3 loop,
also present in the PDXB subfamily (Fig. 3), accommo-
dates a SERA-invariant arginine that directly binds phos-
phate in the crystal structures. The arginine is usually
stabilized by a conserved glutamine residue located in
the α5 helix. The structural regions providing additional
Arg/Lys residues depend on the SERA subtypes: In types
I and IIIH/K, an arginine contacting the substrate is lo-
cated in the β4-α4 loop, whereas in all types except for
IIIK, an extra Arg/Lys residue enters the active site from
the other subunit within the αB′-βA′ loop (Additional
file 8: Figure S4).
New uncharacterized subfamilies
The 13 newly defined subfamilies that were not studied
biochemically (X1-X13) constitute small clades, each
comprising closely related species from bacteria, ar-
chaea, and plants (Fig. 1, Additional file 2: Figure S1).
According to the sequence alignment, almost all new
clades retain the conserved residues of the active site,
thereby suggesting that these proteins probably act as
active dehydrogenases or reductases (Additional file 7:
Figure S3). Only the X13 subfamily lacks the conserved
glycine residue (Gly73 in the β4-α4 loop) that provides
the amide atom to position the substrate relative to the
cofactor, and ~ 50% of members of the X4 subfamily
have the histidine residue of the catalytic triad replaced
with tryptophan, which is accompanied by a loss of the
catalytic glutamate.
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sentatives with a determined 3D structure (Additional
file 2: Figure S1). Among these structures, one was
solved with a cofactor (PDB ID: 1qp8 from X4), another
with a cofactor and a reaction product (PDB ID: 3 kb6
from X9, Additional file 8: Figure S4); the rest of the
structures do not have function-relevant ligands (Add-
itional file 6: Table S2). Below, we provide a short de-
scription of the two subfamilies that have at least one
structure in complex with a cofactor.
The X4 subfamily consists of archaeal enzymes from
Crenarchaeota and Euryarchaeota. The only structure in
complex with a cofactor from this subfamily (PDB ID:
1qp8) corresponds to a protein from Pyrobaculum aero-
philum PAE1175; it is annotated as a putative formate
dehydrogenase in the PDB and as a 2-hydroxyacid de-
hydrogenase in UniProt. Notably, it lacks the catalytic
His and Glu/Gln, instead containing Trp and Val in
these positions, respectively. These substitutions are
unique features of about 50% of the members of this
subfamily (see section: Residues of the active site). Trp is
conserved among PAE1175 homologs from Crenarch-
aeota, leading to questions regarding the molecular
function of these enzymes. The substrate-binding do-
main of PAE1175 possesses a deteriorated version of the
Rossmann fold, with a short hydrogen-bonded turn in-
stead of α2 and a short β-bridge instead of β3. Import-
antly, it lacks features characteristic of FDH subfamily
members, such as a long β3-α3 loop with the PF[HW]P
sequence motif (Fig. 3) and Ile/Val within the β4-α4 loop
(Additional file 8: Figure S4). Therefore, as was con-
cluded from an earlier analysis of its crystal structure, its
role as a formate dehydrogenase seems highly far-
fetched [45]. However, since formate dehydrogenation is
the only reaction catalyzed by 2HADH that does not in-
volve proton transfer, it still may be the most feasible
function of the Trp-substituted enzymes from the X4
subfamily. Interestingly, X4 members from Euryarch-
aeota, such as Ta0858 from Thermoplasma acidophilum
with solved structure (PDB ID: 3gvx) possess the canon-
ical Arg-Glu-His catalytic triad. According to the pattern
of sequence conservation, most members of the subfam-
ily likely display a preference for NADP(H) over NAD
(H), as the topology of the βB-αD loop is highly similar
to that of GHRA (Fig. 3).
The only structure of an X9 subfamily protein with a
co-factor (PDB ID: 3 kb6) corresponds to aq_727 from
Aquifex aeolicus and is annotated as D-lactate dehydro-
genase in both PDB and UniProt. X9 is a sister group to
LDHD (Fig. 1), although representatives of the two sub-
families display relatively low sequence identity (< 40%).
3 kb6 was determined in complex with NAD(H) and
lactic acid (the authors suggested that it could also be
pyruvate, but the electron density clearly suggests thatthe C2 atom of this molecule is sp3 hybridized) [41],
which interacts with the residues in a similar fashion as
those seen in LDHD structures (e.g., PDB ID: 4cuk,
Additional file 8: Figure S4). Therefore, despite a lack of
biochemical evidence, X9 may be regarded as a new sub-
group of D-lactate dehydrogenases.
2HADHs knowledgebase
To simplify navigation over the 2HADHs classification,
we have created a software tool that converts spread-
sheets containing results of our analyses into a
web-based knowledgebase. The 2HADHs knowledgebase
consists of three elements: an explorable phylogenetic
tree of the family, an interactive table with annotations
of the selected enzymes, and a BLAST search tool. Main
clades on the phylogenetic tree are hyperlinked to the
table with annotations of the family representatives. Pro-
tein annotations include a list of kinetically characterized
substrates, highest efficiency substrate, PDB identifiers,
structure ligands, and publication references for struc-
tural and kinetics studies. The protein table content can
be sorted by any column and filtered by source organism
kingdom, availability of kinetics, or structural studies.
All proteins that have the corresponding publication or
an experimentally-determined structure are hyperlinked
to PubMed and the Protein Data Bank, respectively. In
addition, we have generated Molstack [95] visualizations
of active sites for all proteins having a cofactor and a lig-
and bound in this region. Molstack interactive visualiza-
tions give an instant insight into the quality of
macromolecule model and a corresponding electron
density map. The knowledgebase allows to classify an
uncharacterized sequence and find its closest studied
homologs by using a built-in BLAST tool. Its content is
generated automatically from annotation spreadsheets,
what makes it is easy to maintain the information
up-to-date. The 2HADHs knowledgebase is publicly
available at http://2hadh.bioreproducibility.org/.
Discussion
Motivated by recent advances in genetic engineering and
new societal needs, the use of enzymes as catalysts to
synthesize compounds and materials is rapidly expand-
ing. It is apparent that enzyme promiscuity offers great
opportunities in the design and development of new
catalytic functions in the scaffold of stable enzymes [96].
Exploiting enzyme substrate promiscuity might lead to
improvements in existing catalysts and provide novel
synthesis pathways that are currently not available. The
D-2-hydroxyacid dehydrogenases (2HADHs) may be
considered as another protein family in which substrate
promiscuity and moderate-to-high efficiency are a rule
rather than an exception. This feature has already been
used in systems for highly stereoselective production of
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comprehensive understanding of sequence-structure-
function information provides a foundation for future
biotechnological developments.
A refined evolutionary analysis and classification of
the 2HADH family to large extent uphold the previous
observation that most enzymes remain to cluster accord-
ing to their preferential substrates. Moreover, the top-
ology of the refined tree suggests that, besides previously
determined six subfamilies (SERA, FDH, CTBP, PDXB,
LDHD, and GHRB), three others (GHRA, GHRC, and
DDH) with at least one biochemically characterized
member could be established. Moreover, we define 13
other small subfamilies of dehydrogenases that have not
been characterized biochemically. We suggest that
studying representatives of these subfamilies can greatly
help annotation of metabolic pathways of multiple or-
ganisms, as well as may lead to discovery of enzymes
with novel biotechnological applications.
To facilitate application of the collected information,
we provide a publicly available 2HADH enzymes know-
ledge portal, which allows to classify uncharacterized
members and gives insights into the evolutionary history
of substrate specificity of these heterogeneous enzymes.
Although several databases have been developed to store
kinetic parameters of enzymes obtained in steady states
(e.g., BRENDA [97], MetaCyc [98], or UniProt [99]), for
a majority of the protein families, the data are usually
sparse and encompass only subsets of possible sub-
strates. Therefore, to limit the bias and grasp the level to
which the functional annotations can be extra- or inter-
polated, the data should be interpreted in the evolution-
ary context of the whole protein family. The large
number of paralogs, recent duplications and horizontal
transfers make function prediction within the 2HADH
family particularly troublesome. To facilitate usage of
the collected information, the 2HADH portal is
equipped with an interface to search for close homologs
within the representative enzymes and an interactive an-
notation data table. The portal is designed to be easily
maintained and adaptable to the presentation of similar
analysis of other protein families. The 2HADH knowl-
edgebase is available at: http://2hadh.bioreproducibili-
ty.org/.
Conclusions
We present a revised classification of the family that
comprises 22 subfamilies, including 13 new subfamilies
not studied biochemically. For the first time, all available
enzymatic and structural features of the subfamilies were
collected and analyzed in a systematic way, expanding
our understanding of the features contributing to their
core function of D-2-hydroxyacid dehydrogenation, as
well as to their functional diversity exhibited bysubstrate specificities. Our family-wide sequence and
structural comparison proved general importance of sev-
eral active site residues that were not previously dis-
cussed in the literature (e.g., Val72, Gly73, Asn227,
Gly229, and Gly231, with numbering referring to
Q92LZ4_RHIME), extending our understanding of its
catalytic machinery. Systematic analyses of active site en-
vironments provided key insights into the residues im-
portant (or unimportant) for substrate selectivity. In
addition, these analyses have left intriguing uncertainties
regarding the role of dimerization and dynamics of the
secondary structure elements or entire domains, as well
as the molecular mechanism for different substrate am-
biguity. To facilitate usage of the collected biochemical,
structural and evolutionary information, we provide a
dedicated web portal allowing to classify new sequences
and to generate functional hypotheses for further studies
on these largely uncharacterized enzymes.
Methods
Phylogenetic analysis
To reliably classify the 2HADH family into evolutionary
subfamilies, we constructed a phylogenetic tree using
available sequence and structure information. Phylogen-
etic tree building relies primarily on a multiple sequence
alignment (MSA) of sequences of interest. Standard
automatic algorithms for building MSAs do not work
well for sequences with low sequence identity, i.e., below
20–25% [100], but could be considerably improved by
incorporating structural information [101]. For example,
sequence identity between A. thaliana FDH and H. sapi-
ens CTBP1 is 18%, as obtained from a global
Needleman-Wunsch alignment. Given that the existing
2HADH classification relies on an MSA generated auto-
matically with ClustalW [5, 6], we decided to improve it
by using a high-quality, structure-based MSA.
First, literature searches were carried out to identify and
select biochemically confirmed D-2-hydroxyacid dehydro-
genases. The biochemically studied proteins were used as
a “confidently annotated” reference set for the 2HADH
family. Their amino acid sequences were downloaded
from UniProt, trimmed to the cofactor-binding and
substrate-binding domains, and used as queries for
BLAST [102] against the PDB (expectation value < 10− 5,
September 2016) to search for closely homologous en-
zymes with solved structures. 30 selected PDB representa-
tives were used to create a high-quality, structure-based
sequence alignment with PROMALS3D [101] using the
default parameters. The “seed” structures were chosen to
diversely represent the 2HADH sequence space (median
identity between sequences was 23%).
To extend the sequence set, the reference 2HADH en-
zymes with biochemical or structural information was
then used as queries in BLAST searches against 111
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GENOME (Additional file 9: Data file S2). Hits with
E-value < 10− 3 to at least one reference sequence and
with coverage at least 90% of the query sequence were
extracted and aligned with MAFFT 7.123 [100] (“maff-
t-linsi --add”) to the structure-based alignment of the
representative structures. The alignment of 462 se-
quences was manually checked in SeaView 4.5.4 [103],
and trimmed with trimAl to remove columns with gaps
in at least 80% sequences (“trimal -gt 0.2”) [104].
Based on the resulting MSA of 462 sequences, we built
phylogenetic trees using several approaches. Phylogen-
etic inference was carried out using neighbor-joining
(NJ) and maximum-likelihood (ML) methods. The NJ
tree was calculated with BioNJ [105] (Poisson distance,
100 bootstrap replicas, and JTT model). The ML trees
were computed with FastTree 2.1.7 [106] (WAG+CAT
evolutionary model, discrete gamma model with 20 rate
categories and Shimodaira-Hasegawa test for estimation
of local support values) and RAxML 8.2.7 [107] (100
bootstrap replicas, WAG evolutionary model, and esti-
mated gamma distribution parameter: “-T 100 -f a -m
PROTGAMMAWAG -p 12345 -x 12345 -# 100”). The
obtained trees were visualized with Archaeopteryx [108].
Structure analysis
Crystal structures deposited in the PDB were collected
with BLAST via the RCSB PDB RESTful interface [109],
using sequences of the functionally annotated 2HADHs
as queries (with E-value threshold of 10− 5). The struc-
tures were then analyzed with BioPython [110] and
PyMol [111]. The complete list of the analyzed struc-
tures can be found in Additional file 6: Table S2.
In the 40 structures solved with both a cofactor and a
ligand analog bound in the active site, we mapped resi-
dues within 5 Å from the bound substrate (Additional
file 8: Figure S4).
Web server
The web server was created in JavaScript and Node.js
run-time environment. The BLAST database of the 462
sequences was generated with “makeblastdb”. Sequence
searching is carried out using “blastp” command with
default parameters [102]. The web server is accessible at
http://2hadh.bioreproducibility.org/.
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subfamilies aligned with the reference sequence of Rhizobium meliloti
GHRB (Q92LZ4). The structure-based alignment was obtained for selected
structures with PROMALS3D and used as a seed alignment for other
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except for the fragment of the PDXB dimerization domain (“PDXB-dim”).
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